Plano TX Cosmetic Dentist Implant Dentistry & Family Dental Services Announced

The leading Plano, Texas dental practice Millennium Dental, with appointments available at 972-491-2677, announced an expansion of the coveted general, cosmetic and restorative dentistry it is able to provide to help patients in the community maintain the most beautiful, healthy smile.

Plano, United States - September 13, 2017 /PressCable/ —

The award winning dental clinic Millennium Dental has announced an expansion of the popular general, cosmetic and reconstructive dentistry services it is able to provide patients in Plano, Texas, and its surrounding areas.

More information is available at https://www.millenniumdds.com/.

The Millennium Dental is the most popular and highest rated dental practice in Plano, Texas, for its extensive experience helping patients of all ages in the community enjoy a beautiful, healthy smile with its proven range of preventive, cosmetic and reconstructive dentistry at prices anyone can afford.

The dental practice has announced an expansion of the award winning dentistry it is able to provide, which includes all the routine cleanings, oral cancer screenings or periodontal treatments needed to help maintain peek oral health and the custom veneers, bridges, crowns, implants, dentures or teeth whitening to restore a white, functional smile patients can be confident about.

This industry leading range of general, cosmetic and reconstructive dentistry is delivered by a team of friendly dental assistants and hygienists led by board certified dentist Dr. Jana Harrison who are known for combining the most gentle, individualized approach to dental care with a warm, welcoming environment to ensure a comfortable experience for each and every patient. More information at https://www.millenniumdds.com/porcelain-veneers/

The Millennium Dental team explains that “our practice is committed to dental excellence and superior patient care. We want to help each and every one of our patients experience the comfort and confidence that comes with a beautiful, healthy smile and our top priority, from the moment they walk through the door, is their comfort and satisfaction. We invite everyone to come discover the difference we can make in their life and why we’re Plano’s choice for dentistry.”

Appointments and consultations with Millennium Dental or more information on the complete range of dental services it is able to provide can be requested at 972-491-2677 or through the website link provided above along with multiple patient testimonials and before & after smile galleries showcasing its unique dentistry skill and patient care philosophy or a virtual tour of its offices conveniently located at 7705 San Jacinto Place, Ste. 400, Plano, Texas.

Contact Info:
Name: Dr. Jana Harrison
Organization: Millennium Dental
Address: 7705 San Jacinto Pl #400, Plano, TX 75024, United States

For more information, please visit https://www.millenniumdds.com/

Source: PressCable

Release ID: 238628

Latest News

EU charges Merck KGaA, GE, Canon of misleading merger info

Sep 25, 2017

By Foo Yun CheeBRUSSELS (Reuters) - General Electric , German drugmaker Merck KGaA , and Japan's Canon risk hefty fines after EU antitrust regulators accused them of providing misleading information during separate merger deals.The European Commission said on Thursday that it had sent three separate charge sheets known as statements of objections to General Electric, Merck KGaA and Canon after investigations showed breaches of the bloc's merger rules.While the charges will not affect the EU approvals of the deals, they could lead to fines up to 1 percent of global revenue for Merck KGaA and General Electric, and up to...

Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion

Sep 25, 2017

By Sam NusseyTOKYO (Reuters) - Konica Minolta Inc said it was purchasing U.S. diagnostics company Ambry Genetics in a deal valued at up to $1 billion - an acquisition that marks a strategic shift for the Japanese firm's healthcare business as it seeks a leading position in precision medicine.The deal is the largest ever for the photocopier maker, which has been seeking to diversify away its office equipment business. It pulled out of cameras about a decade ago.Konica Minolta said its advanced imaging technology complemented privately held Ambry's genetic testing capabilities, with initial applications for combining the technologies seen in...

Oxford BioMedica wins big contract for Novartis cell therapy

Sep 25, 2017

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019.The deal, announced by Oxford BioMedica on Thursday, could help put the veteran biotech firm on a path to sustainable profitability.The contract is for the supply of lentiviral vectors used to generate CTL019, a new kind of treatment for hard-to-treat leukemia that is expected to reach the market this year.A U.S. advisory panel will discuss the case for approving CTL019 at a meeting...

Novartis receives EU approval for Cosentyx label update

Sep 25, 2017

ZURICH (Reuters) - Novartis said that the Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Cosentyx (secukinumab), the first interleukin-17A (IL-17A) approved to treat psoriasis.The label update includes 52 week data from the CLEAR study demonstrating the long-term superiority of Cosentyx versus Stelara (ustekinumab) in psoriasis, a common, non-contagious, auto-immune disease, the Swiss pharmaceutials company said on Thursday. (Reporting by Silke Koltrowitz)

FDA puts hold on Merck multiple myeloma trials after deaths

Sep 25, 2017

(Reuters) - Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy.The rare setback for Keytruda sent Merck shares more than 1 percent lower.Merck has been on a roll with the medicine, jumping to the front of the pack of companies with new immuno-oncology drugs, particularly after Keytruda extended survival as an initial treatment for advanced lung cancer, by far the largest oncology market. Bristol-Myers...

Search
Top News
You May Need To Know

About Us

The Healthier Web delivers accurate and up-to-date health information through medical content and insights from experts. Feel the ‘ohm’ here in The Healthier Web.

Contact us: sales@thehealthierweb.com